Market OverviewThe Global Smart Insulin Pens Market was valued USD 102.86 Million in 2022 and is anticipated to reach a value ...
Health sector stocks fluctuate amid DOJ probe into UnitedHealth (UNH), Gilead upgrade for HIV treatments, and Moderna's focus on non-COVID approvals.
IEUR's holdings include Europe's innovative GRANOLAS and Germany's Mag7, providing a strong backbone and momentum for the ETF. Read why IEUR is a Strong Buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback